Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-12 04:09 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
Anti-inflammatory Drug Algorithm for COVID-19 Home Treatment
NCT05249790 · Mario Negri Institute for Pharmacological Research · PHASE3 · withdrawn · last registry update 2024-11-29 · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
What was said, and by whom
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | “authorization denied” | – | Registry record, Mario Negri Institute for Pharmacological Research |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against NR3C1 within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
- 2025-10-23Phase 3 first posted: SWOG Cancer Research Network, Cyclophosphamide + Doxorubicin Hydrochloride (NCT07220187)
- 2025-09-22Results posted on the registry: St. Jude Children's Research Hospital, Venetoclax + Navitoclax (NCT05192889)
- 2025-07-18Phase 3 first posted: Children's Oncology Group, Bortezomib + Calaspargase Pegol (NCT07072585)
- 2025-06-25Phase 3 first posted: Centre Hospitalier Universitaire, Amiens, hydrocortisone plus fludrocortisone + placebo of hydrocortisone plus fludrocortisone (NCT07037043)
- 2025-04-08Phase 3 first posted: Laboratorios Silanes S.A. de C.V., Desloratadine / Betamethasone in fixed dose + Desloratadine (NCT06916884)
- 2025-02-24Results posted on the registry: Neurocrine UK Limited, Chronocort + Cortef (NCT05063994)
- 2024-10-24Results posted on the registry: Neurocrine UK Limited, Hydrocortisone (NCT03062280)
- 2024-09-24Results posted on the registry: National Cancer Institute (NCI), Blinatumomab + Cyclophosphamide (NCT02003222)
- 2024-07-11Phase 3 first posted: Fayoum University, Methylprednisolone + Dexamethasone (NCT06496997)
- 2024-03-12Results posted on the registry: National Cancer Institute (NCI), Clofarabine + Cyclophosphamide (NCT02883049)
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision